Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women

References

• Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States, 2011-2015. Natl Health Stat Report. 2017;104:1–23.
   Google Scholar
• Martinez G, Copen CE, Abma JC. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. Vital Health Stat 23. 2011;31:1–35.
   PubMedGoogle Scholar
• Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 2016;374(9):843–852.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adolescent sexual reproductive health. 2020. https://www.who.int/southeastasia/activities/adolescent-sexual-reproductive-health.
   Google Scholar
• Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group. The American college of obstetricians and gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120(4):983–988.
   PubMedGoogle Scholar
• Diedrich JT, Klein DA, Peipert JF. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(4):364.e1–364.e12.
   PubMed Web of Science ®Google Scholar
• Bahamondes MV, Bahamondes L. Intrauterine device use is safe among nulligravidas and adolescent girls. Acta Obstet Gynecol Scand. 2021;100(4):641–648.
   PubMed Web of Science ®Google Scholar
• Jatlaoui TC, Riley HEM, Curtis KM. The safety of intrauterine devices among young women: a systematic review. Contraception. 2017;95(1):17–39.
   PubMed Web of Science ®Google Scholar
• WHO. Medical Eligibility Criteria for contraceptive use. 5th edn. WHO. 2015. https://www.who.int/publications/i/item/9789241549158
   Google Scholar
• Keenahan L, Bercaw-Pratt JL, Adeyemi O, et al. Rates of intrauterine device expulsion among adolescents and young women. J Pediatr Adolesc Gynecol. 2021;34(3):362–365.
   PubMed Web of Science ®Google Scholar
• Rivera R, Chen-Mok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception. 1999;60(3):155–160.
   PubMed Web of Science ®Google Scholar
• Simonatto P, Bahamondes MV, Fernandes A, et al. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system. J Obstet Gynaecol Res. 2016;42(5):554–559.
   PubMed Web of Science ®Google Scholar
• Madden T, McNicholas C, Zhao Q, et al. Association of age and parity with intrauterine device expulsion. Obstet Gynecol. 2014;124(4):718–726.
   PubMed Web of Science ®Google Scholar
• Alton TM, Brock GN, Yang D, et al. Retrospective review of intrauterine device in adolescent and young women. J Pediatr Adolesc Gynecol. 2012;25(3):195–200.
   PubMed Web of Science ®Google Scholar
• Aoun J, Dines VA, Stovall DW, et al. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123(3):585–592.
   PubMed Web of Science ®Google Scholar
• Behringer T, Reeves MF, Rossiter B, et al. Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women. Contraception. 2011;84(5):e5–e10.
   PubMedGoogle Scholar
• Ravi A, Prine L, Waltermaurer E, et al. Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network. J Am Board Fam Med. 2014;27(6):822–830.
   PubMed Web of Science ®Google Scholar
• Teal SB, Romer SE, Goldthwaite LM, et al. Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol. 2015;213(4):515.e1-5–515.e5.
   PubMed Web of Science ®Google Scholar
• Ravi A, Prine L, Waltermaurer E, et al. Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network. J Am Board Fam Med. 2014;27(6):822–830.
   Google Scholar
• Teal SB, Romer S, Goldthwaite LM, et al. Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol. 2015;213(4):515.e1–515.e5.
   Google Scholar
• Vaitsiakhovich T, Filonenko A, Lynen R, et al. C. Cross design analysis of randomized and observational data - application to continuation rates for a contraceptive intra uterine device containing levonorgestrel in adolescents and adults. BMC Womens Health. 2018;18(1):180.
   PubMedGoogle Scholar
• Teunissen AM, Merry AHH, Devies IEC, et al. Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg. Eur J Contracept Reprod Health Care. 2019;24(6):449–456.
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Akira S, Harada T, et al. Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI). Eur J Contracept Reprod Health Care. 2022;27(4):300–307.
   PubMed Web of Science ®Google Scholar
• Ilyin AB, Khasanov AA, Suturina LV, et al. Comparison of two levonorgestrel-releasing intrauterine systems for the treatment of heavy menstrual bleeding: a randomised, controlled, phase 3 trial. Eur J Contracept Reprod Health Care. 2021;26(6):491–498.
   PubMed Web of Science ®Google Scholar
• Patseadou M, Michala L. Usage of the levonorgestrel-releasing intrauterine system (52 MG LNG-IUD) in adolescence: what is the evidence so far? Arch Gynecol Obstet. 2017;295(3):529–541.
   PubMed Web of Science ®Google Scholar
• Diaz J, Pinto-Neto AM, Bahamondes L, et al. Performance of the copper T 200 in parous adolescents: are copper IUDs suitable for these women? Contraception. 1993;48(1):23–28.
   PubMed Web of Science ®Google Scholar
• Laporte M, Peloggia A, Marcelino AC, et al. Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system. Eur J Contracept Reprod Health Care. 2022;27(3):208–211.
   PubMed Web of Science ®Google Scholar